UPDATE 1-Amgen, Allergan say Avastin copycat succeeds in lung cancer study
 

UPDATE 1-Amgen, Allergan say Avastin copycat succeeds in lung cancer study
Sept 23 (Reuters) - Amgen Inc and Allergan Plc said a late-stage study showed their biosimilar candidate for a type of lung cancer was as effective as Roche AG's Avastin in preventing disease progression and improving survival.


http://rc.feedsportal.com/r/23838622...14/rc/1/rc.img

http://rc.feedsportal.com/r/23838622...14/rc/2/rc.img

http://rc.feedsportal.com/r/23838622...14/rc/3/rc.img

http://da.feedsportal.com/r/23838622...2/sc/14/a2.img
http://adchoice.feedsportal.com/r/23.../sc/14/ach.imghttp://pi.feedsportal.com/r/23838622.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2383862...sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...4Q:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...4Q:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/JcsuYuPXRr0